Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation
Ayumi Yoshizaki(University of Tokyo Hospital), Shinichi Sato(University of Tokyo Hospital)
Cited by 60
Related Papers
Linoleic Acid, Other Fatty Acids, and the Risk of Stroke
|Stroke|2002|247
Serum Total Homocysteine Concentrations and Risk of Stroke and Its Subtypes in Japanese
|Circulation|2004|144
Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis
|Nature Communications|2014|143
CD19, a Response Regulator of B Lymphocytes, Regulates Wound Healing through Hyaluronan-Induced TLR4 Signaling
|American Journal Of Pathology|2009|104
Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis
|Nature Communications|2021|79